These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 15994200

  • 1. Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases.
    Jung HS, Kim DW, Jo YS, Chung HK, Song JH, Park JS, Park KC, Park SH, Hwang JH, Jo KW, Shong M.
    Mol Endocrinol; 2005 Nov; 19(11):2748-59. PubMed ID: 15994200
    [Abstract] [Full Text] [Related]

  • 2. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW, Hwang JH, Suh JM, Kim H, Song JH, Hwang ES, Hwang IY, Park KC, Chung HK, Kim JM, Park J, Hemmings BA, Shong M.
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.
    Kim YR, Byun HS, Won M, Park KA, Kim JM, Choi BL, Lee H, Hong JH, Park J, Seok JH, Kim DW, Shong M, Park SK, Hur GM.
    BMC Cancer; 2008 May 23; 8():144. PubMed ID: 18498667
    [Abstract] [Full Text] [Related]

  • 7. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
    Kim DW, Chung HK, Park KC, Hwang JH, Jo YS, Chung J, Kalvakolanu DV, Resta N, Shong M.
    Mol Endocrinol; 2007 Dec 23; 21(12):3039-49. PubMed ID: 17761947
    [Abstract] [Full Text] [Related]

  • 8. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
    Lodyga M, De Falco V, Bai XH, Kapus A, Melillo RM, Santoro M, Liu M.
    Oncogene; 2009 Feb 19; 28(7):937-49. PubMed ID: 19060924
    [Abstract] [Full Text] [Related]

  • 9. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G.
    Oncogene; 1992 Nov 19; 7(11):2189-94. PubMed ID: 1437145
    [Abstract] [Full Text] [Related]

  • 10. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase.
    De Falco V, Castellone MD, De Vita G, Cirafici AM, Hershman JM, Guerrero C, Fusco A, Melillo RM, Santoro M.
    Cancer Res; 2007 Jan 01; 67(1):381-90. PubMed ID: 17210721
    [Abstract] [Full Text] [Related]

  • 11. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV.
    Mol Biol (Mosk); 2004 Jan 01; 38(4):642-53. PubMed ID: 15456136
    [Abstract] [Full Text] [Related]

  • 12. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM, Cirafici AM, De Falco V, Bellantoni M, Chiappetta G, Fusco A, Carlomagno F, Picascia A, Tramontano D, Tallini G, Santoro M.
    Am J Pathol; 2004 Aug 01; 165(2):511-21. PubMed ID: 15277225
    [Abstract] [Full Text] [Related]

  • 13. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
    Castellone MD, Cirafici AM, De Vita G, De Falco V, Malorni L, Tallini G, Fagin JA, Fusco A, Melillo RM, Santoro M.
    Oncogene; 2003 Jan 16; 22(2):246-55. PubMed ID: 12527893
    [Abstract] [Full Text] [Related]

  • 14. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.
    Kim DW, Jo YS, Jung HS, Chung HK, Song JH, Park KC, Park SH, Hwang JH, Rha SY, Kweon GR, Lee SJ, Jo KW, Shong M.
    J Clin Endocrinol Metab; 2006 Oct 16; 91(10):4070-6. PubMed ID: 16849418
    [Abstract] [Full Text] [Related]

  • 15. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS, Gujral TS, Peng S, Asa SL, Mulligan LM.
    Cancer Res; 2009 Jun 01; 69(11):4861-9. PubMed ID: 19487296
    [Abstract] [Full Text] [Related]

  • 16. The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC.
    Rusciano MR, Salzano M, Monaco S, Sapio MR, Illario M, De Falco V, Santoro M, Campiglia P, Pastore L, Fenzi G, Rossi G, Vitale M.
    Endocr Relat Cancer; 2010 Mar 01; 17(1):113-23. PubMed ID: 19903742
    [Abstract] [Full Text] [Related]

  • 17. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A.
    Br J Cancer; 2001 Dec 14; 85(12):1831-7. PubMed ID: 11747322
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 19. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
    Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK.
    Cancer; 2010 Jun 15; 116(12):2974-83. PubMed ID: 20564403
    [Abstract] [Full Text] [Related]

  • 20. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
    Santoro M, Melillo RM, Fusco A.
    Eur J Endocrinol; 2006 Nov 15; 155(5):645-53. PubMed ID: 17062879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.